John Smith, 01/01/1970
1234567
01 November 2024
**Diagnosis:**
* Rheumatoid Arthritis, diagnosed 2018
**Clinical Phenotype:**
Patient presents with symmetrical polyarthritis affecting the small joints of the hands and feet. Positive for rheumatoid factor and anti-CCP antibodies.
**Relevant Medications:**
Current medication:
* Methotrexate 15mg weekly, subcutaneous injection
* Prednisolone 5mg daily
**Previous Rheumatology Medications / DMARDs / Biological Therapy:**
* Adalimumab (Humira) - discontinued due to inefficacy
* Leflunomide - discontinued due to side effects
**Allergies:**
Patient reports an allergy to penicillin, resulting in a rash.
**Notable Comorbidities:**
Patient has a history of hypertension, well-controlled with medication. Family history of rheumatoid arthritis in mother.
Patient reports persistent joint pain and stiffness, particularly in the morning. Fatigue is also a significant symptom.
**Examination findings**
* Swelling and tenderness in the metacarpophalangeal joints.
* Reduced range of motion in the wrists.
* Slightly warm to the touch.
**Investigations:**
* Repeat full blood count, ESR, CRP
* Rheumatoid factor and anti-CCP antibodies
* X-rays of hands and feet
**Assessment:**
Chaperone was present during the examination.
* Disease activity remains high despite current treatment.
* Patient reports significant impact on daily activities.
* Patient is keen to explore alternative treatment options.
Examination findings
* Swelling and tenderness in the metacarpophalangeal joints.
* Reduced range of motion in the wrists.
* Slightly warm to the touch.
**Plan:**
* Increase Methotrexate to 20mg weekly.
* Consider switching to a biologic agent if symptoms persist.
* Continue Prednisolone at current dose.
* Referral to a rheumatology nurse specialist for education and support.
* Review of current medications and potential side effects.
**Follow up:**
Follow-up appointment in 4 weeks.
Dr. Hannah Khan
MBBS, MRCP, Rheumatologist
hkhan@ahdubai.com